These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32407867)

  • 1. Effect of vitamin D nutrition on disease indices in patients with primary hyperparathyroidism.
    Rao SD; Miragaya J; Parikh N; Honasoge M; Springer K; Van Harn M; Divine GW
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105695. PubMed ID: 32407867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications.
    Rao DS; Honasoge M; Divine GW; Phillips ER; Lee MW; Ansari MR; Talpos GB; Parfitt AM
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1054-8. PubMed ID: 10720039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism.
    Ozbey N; Erbil Y; Ademoğlu E; Ozarmağan S; Barbaros U; Bozbora A
    World J Surg; 2006 Mar; 30(3):321-6. PubMed ID: 16467981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
    Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
    Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region.
    Raef H; Ingemansson S; Sobhi S; Sultan A; Ahmed M; Chaudhry M
    J Endocrinol Invest; 2004 Oct; 27(9):807-12. PubMed ID: 15648543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of plasma 25-hydroxyvitamin D levels with severity of primary hyperparathyroidism and likelihood of parathyroid adenoma localization on sestamibi scan.
    Kandil E; Tufaro AP; Carson KA; Lin F; Somervell H; Farrag T; Dackiw A; Zeiger M; Tufano RP
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1071-5. PubMed ID: 18936353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective.
    Rao DS; Agarwal G; Talpos GB; Phillips ER; Bandeira F; Mishra SK; Mithal A
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N75-80. PubMed ID: 12412781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of vitamin D status and tumor size on the intraoperative parathyroid hormone dynamics in patients with symptomatic primary hyperparathyroidism.
    Agarwal G; Sadacharan D; Ramakant P; Shukla M; Mishra SK
    Surg Today; 2012 Dec; 42(12):1183-8. PubMed ID: 22218874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large parathyroid adenomas: Potential mechanisms to reconcile adenoma size and disease phenotype.
    Bhan A; Athimulam S; Kumari P; Pal R; Bhadada SK; Cook BC; Qiu S; Rao SD
    Front Endocrinol (Lausanne); 2023; 14():1009516. PubMed ID: 36817587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory profile of primary hyperparathyroidism in India.
    Priya G; Jyotsna VP; Gupta N; Chumber S; Bal CS; Karak AK; Seth A; Ammini AC
    Postgrad Med J; 2008 Jan; 84(987):34-9. PubMed ID: 18230749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 25-hydroxyvitamin D status does not affect intraoperative parathyroid hormone dynamics in patients with primary hyperparathyroidism.
    Adler JT; Sippel RS; Chen H
    Ann Surg Oncol; 2010 Nov; 17(11):2958-62. PubMed ID: 20544293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of baseline intact parathyroid hormone levels on severity of primary hyperparathyroidism and outcomes in patients undergoing surgery.
    Kandil E; Alabbas H; Tufaro AP; Carson KA; Tufano RP
    Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):147-50. PubMed ID: 20157060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism.
    Silverberg SJ; Shane E; Dempster DW; Bilezikian JP
    Am J Med; 1999 Dec; 107(6):561-7. PubMed ID: 10625024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low vitamin D levels have become less common in primary hyperparathyroidism.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
    Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D Status and Indices of Mineral Homeostasis in the Population: Differences Between 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D.
    Cirillo M; Bilancio G; Guarino E; Cavallo P; Lombardi C; Costanzo S; De Curtis A; Di Castelnuovo A; Iacoviello L
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31374914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy.
    Stewart ZA; Blackford A; Somervell H; Friedman K; Garrett-Mayer E; Dackiw AP; Zeiger MA
    Surgery; 2005 Dec; 138(6):1018-25; discussion 1025-6. PubMed ID: 16360386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severe hypercalcemia after substitution of prolonged deficiency of vitamin D in a patient with primary hyperparathyroidism].
    Duquenne M; Duquenne C; Souberbielle JC; Hamy A; Rohmer V
    Presse Med; 2014 Dec; 43(12 Pt 1):1391-4. PubMed ID: 25443637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.